This report provides an overview of the key findings and recommendations associated with Meningococcal B community catch up clinics and mobile vaccination services for Counties Manukau, Northland, Waitemata and Auckland District Health Boards. It is one of a series of reports commissioned by the Ministry of Health to inform and evaluate the Meningococcal B immunisation programme. The evaluation was carried out by CBG health Research Ltd.
The objective of the Meningococcal B programme (the programme) was to vaccinate 90% of children aged 6 weeks to 19 years with 3 doses of MeNZB.
The programme was rolled out in three phases.
- Phase 1 in Counties Manukau and the Eastern corridor of Auckland only (vaccinations began in 19 July 2004 for primary care and 2nd August for schools)
- Phase 2, which extended the programme to greater Auckland (primary care vaccinations began on November 1 2004 in the rest of Auckland DHB, November 8, 2004 in Waitemata DHB and November 22nd in Northland DHB).
- Phase 3 - The national roll out, which extended the programme to the rest of the country (primary care vaccinations began in Waikato DHB on 1 February 2005; the schools programme began in Waitemata on 17 march 2005).
As part of the evaluation of phase 3 – the national roll out five DHB implementation - five case studies were completed. Recommendations from the case studies were designed to be a resource to
- those DHBS who took part in the studies
- those DHBS beginning later in the roll out, so they could learn from other DHBs experience.
as well as providing data for the overall evaluation of the national roll out. The focus of this case study is community catch up clinics and mobile vaccination services in Counties Manukau, Northland, Waitemata and Auckland District Health Boards.